Press Releases
ERGOMED announces launch of its Rare Disease Innovation Center
ERGOMED plc a leading Clinical Research Organization focused on rare disease drug development today announced the establishment of its Rare Disease Innovation Center.
Rare diseases impact around 300 million people worldwide. For each disease, clinical trial sponsors face major challenges...
Packaging & Labelling
Recipharm invests in new high-speed filling line to meet demand for aseptic products
Global contract development and manufacturing organisation (CDMO), Recipharm, is investing to expand its sterile fill and finish production capabilities at its site in Monts, France.
The manufacturing facility which specialises in the aseptic filling of pharmaceutical products, including biologics into...
Packaging & Labelling
PeliBioThermal Opens First Network Station in China
PeliBioThermal, the life science industry’s cold chain partner from discovery to distribution, announces the opening of its first network station in China. Located in Shanghai, the new network station will serve worldwide customers of the Cr?do™ on Demand rental...
Packaging & Labelling
Qatar Airways Cargo welcomes Envirotainer’s newest innovation: the Releye RAP
Qatar Airways Cargo approves Envirotainer’s latest innovation – The Releye® RAP container. Officially launched on 9 February 2022, and able to accommodate 5 pallets, the Releye® RAP is the largest and most technically advanced product in Envirotainer’s new generation...
Press Releases
Moderna Expands Global Footprint Through Commercial Partnership with Adium in Latin America
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced a distribution service agreement with Adium Pharma S.A., a leading private Latin American pharmaceutical company, to support the commercialization of the Moderna COVID-19 vaccine, Spikevax across...
Press Releases
Honeywell Teams With AstraZeneca To Develop Next-Generation Respiratory Inhalers That Use Near-Zero Global Warming Potential Propellant
Honeywell announced a commercial partnership with AstraZeneca to develop and bring to market next-generation respiratory inhalers that use near-zero global warming potential (GWP) propellants to treat asthma and chronic obstructive pulmonary disease (COPD).
As many as 384 million people suffer...
Drug Research
BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer
BioNTech SE and Medigene AG, a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies, announced that they have entered a multi-target research collaboration to develop T cell receptor (TCR) based immunotherapies against cancer. The initial term...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.